|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
1
|
Resverlogix Corp.
|
Mar 23, 2020 09:57PM
|
|
Re: Recent changes
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 31, 2019 03:34PM
|
|
Re: Recent article; published in Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Jan 13, 2023 02:04PM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
3
|
Resverlogix Corp.
|
Jul 16, 2019 01:13PM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
1
|
Resverlogix Corp.
|
Jul 16, 2019 06:18PM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
2
|
Resverlogix Corp.
|
Jul 17, 2019 05:53AM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
2
|
Resverlogix Corp.
|
Jul 17, 2019 10:05AM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
4
|
Resverlogix Corp.
|
Jul 16, 2019 06:08AM
|
|
Re: Received a response....Third Eye Loan Balance
|
2
|
Resverlogix Corp.
|
Jul 14, 2019 09:14AM
|
|
Re: Received a response....Third Eye Loan Balance
|
1
|
Resverlogix Corp.
|
Jul 14, 2019 11:17AM
|
|
Re: Received a response....Third Eye Loan Balance
|
|
Resverlogix Corp.
|
Jul 14, 2019 05:20PM
|
|
Re: Received a response....Third Eye Loan Balance
|
1
|
Resverlogix Corp.
|
Jul 15, 2019 06:10AM
|
|
Re: realisticly how long do they even have to try & close this "purposed offering" 4-6 weeks max?
|
2
|
Resverlogix Corp.
|
May 15, 2019 10:05AM
|
|
Re: realisticly how long do they even have to try & close this "purposed offering" 4-6 weeks max?
|
3
|
Resverlogix Corp.
|
May 15, 2019 10:11AM
|
|
Re: Reaching 250 MACE
|
1
|
Resverlogix Corp.
|
Apr 23, 2019 11:10AM
|
|
Re: Re San fran
|
1
|
Resverlogix Corp.
|
Oct 19, 2020 02:33PM
|
|
Re: Re San fran
|
2
|
Resverlogix Corp.
|
Oct 19, 2020 04:18PM
|
|
Re: RBC unregistered to registered account
|
|
Zenith Epigenetics
|
Mar 29, 2019 07:46AM
|
|
Re: RBC unregistered to registered account
|
1
|
Zenith Epigenetics
|
Apr 02, 2019 07:20AM
|
|
Re: RBC unregistered to registered account
|
2
|
Zenith Epigenetics
|
Apr 02, 2019 07:47AM
|
